Delivery Order SPE2DB20D7059-SPE2DB25FQAC0

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,211.68 firm fixed-price delivery order is for the provision of PEDVAXHIB 0.5ML 10S, a vaccine product. The award has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,817.10 firm-fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,673.55 firm fixed-price delivery order is for PEDVAXHIB vaccine vials (0.5 mL) and has a completion date of February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,752.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PEDVAXHIB vaccine vials, with an ultimate completion date of September 18, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,560.26, is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, a vaccine product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 23, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $5,299.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The delivery order contract is for the supply of PEDVAXHIB 0.5ML 10S, a medical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,977.00 firm fixed-price delivery order is for the supply of 0.5 mL vials of the PEDVAXHIB vaccine. The award has an ultimate completion date of October 30, 2024 and was made on October 29, 2024. There was no set-aside designation for this contract. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award, with an ID of SPE2DB24D1104 | SPE2DB25FXVA3, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,271.97 firm-fixed-price delivery order is for the supply of PEDVAXHIB VACCINE VIAL 0.5ML medical products. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA). The $1,752.30 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of September 25, 2023 and was awarded on September 22, 2023. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of PEDVAXHIB vaccine vials. The $2,716.80 firm-fixed-price contract has a completion date of May 3, 2024 and is not set aside for any specific business category. Amerisourcebergen holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQAC0
    Delivery Order

This federal contract award, valued at $1,895.90, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of PEDVAXHIB vaccine vials, a critical medical commodity. The contract has a period of performance through February 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:09 AM